PROCEEDINGS VOLUME 3191
BIOS EUROPE '97 | 4-8 SEPTEMBER 1997
Photochemotherapy: Photodynamic Therapy and Other Modalities III
IN THIS VOLUME

0 Sessions, 46 Papers, 0 Presentations
PDT-Bacteria  (3)
ALA-PDT  (4)
BIOS EUROPE '97
4-8 September 1997
San Remo, Italy
Basic Studies
Proc. SPIE 3191, Dynamics of photosensitizers in cell cultures and nonanimal in-vivo systems, 0000 (29 December 1997); doi: 10.1117/12.297787
Proc. SPIE 3191, Photodynamic treatment with BPD-MA (verteporfin) activated with light within different spectral ranges, 0000 (29 December 1997); doi: 10.1117/12.297797
Proc. SPIE 3191, In-situ localization of a photosensitizer as evaluated by vital microscopy, 0000 (29 December 1997); doi: 10.1117/12.297802
Proc. SPIE 3191, Detection of oxygen-based radicals using electron spin resonance under PDT conditions, 0000 (29 December 1997); doi: 10.1117/12.297808
Proc. SPIE 3191, Quantitative studies on photodynamic effects, 0000 (29 December 1997); doi: 10.1117/12.297817
Proc. SPIE 3191, Modular diffuse reflection and fluorescence emission imaging colorimeter for the in-vivo study of parameters related to the phototoxic effect in PDT, 0000 (29 December 1997); doi: 10.1117/12.297830
Proc. SPIE 3191, Absorption spectroscopy as a tool to control blood oxygen saturation during photodynamic therapy, 0000 (29 December 1997); doi: 10.1117/12.297831
PDT-Bacteria
Proc. SPIE 3191, Lethal photosensitization of biofilm-grown bacteria, 0000 (29 December 1997); doi: 10.1117/12.297832
Proc. SPIE 3191, Immobilized photosensitizers: photosensitizer films with microbicidal effects, 0000 (29 December 1997); doi: 10.1117/12.297788
Proc. SPIE 3191, Induction of endogenic porphyrin production in bacteria and subsequent photoinactivation by various light sources, 0000 (29 December 1997); doi: 10.1117/12.297789
Cellular Studies
Proc. SPIE 3191, Photodynamically induced cell cycle and gene expression changes: precursors of apoptosis introduction?, 0000 (29 December 1997); doi: 10.1117/12.297790
Proc. SPIE 3191, Different pathways to apoptosis induced by tetraphenylporphine derivatives and light in V79 cells, 0000 (29 December 1997); doi: 10.1117/12.297791
Proc. SPIE 3191, Collagen-gel-induced resistance of overlying keratinocyte cultures to photosensitization, 0000 (29 December 1997); doi: 10.1117/12.297792
Proc. SPIE 3191, Phenomenon of PDT-induced post-irradiation apoptosis in biological liquids cancer cells using sulphonated phthalocyanine aluminum photosensitizer, 0000 (29 December 1997); doi: 10.1117/12.297793
Proc. SPIE 3191, Photodynamic nerve cell killing: dynamics of electrophysiological responses and comparison of photosensitizers, 0000 (29 December 1997); doi: 10.1117/12.297794
Proc. SPIE 3191, Activity of sodium pump in photosensitized cultured rat cardiomyocytes, 0000 (29 December 1997); doi: 10.1117/12.297795
Proc. SPIE 3191, Alteration of mitochondrial membrane potential in photosensitized cardiocytes monitored by fast-response fluorescent probe, 0000 (29 December 1997); doi: 10.1117/12.297796
Proc. SPIE 3191, Photosensitization of tumor cells: are comparable conditions an impossible dream?, 0000 (29 December 1997); doi: 10.1117/12.297798
Preclinical Studies
Proc. SPIE 3191, Infusion technique allowing long-term tumor targeting with antibodies on the hen's egg test (HET) system, 0000 (29 December 1997); doi: 10.1117/12.297799
Proc. SPIE 3191, Improvement of cancer PDT using sulphophthalocyanine and sodium ascorbate, 0000 (29 December 1997); doi: 10.1117/12.297800
Proc. SPIE 3191, In-vivo photodynamic activity of mTHPC poly(ethylene glycol) conjugates (SC102), 0000 (29 December 1997); doi: 10.1117/12.297801
Proc. SPIE 3191, Systemic estimation of the effect of photodynamic therapy of cancer, 0000 (29 December 1997); doi: 10.1117/12.297803
Proc. SPIE 3191, Phosphosubstituted phthalocyanine derivatives as effective photosensitizers for PDT, 0000 (29 December 1997); doi: 10.1117/12.297804
ALA-PDT
Proc. SPIE 3191, New directions in ALA-PDT, 0000 (29 December 1997); doi: 10.1117/12.297805
Proc. SPIE 3191, Initial evaluation of whole bladder wall photodynamic therapy after intravesical ALA sensitization for carcinoma in situ of the bladder, 0000 (29 December 1997); doi: 10.1117/12.297806
Proc. SPIE 3191, Prediction of ALA-PDT efficacy through remote color inspection and post-therapy sequential histologic observations of skin malignancies, 0000 (29 December 1997); doi: 10.1117/12.297807
Non-ALA clinical PDT
Proc. SPIE 3191, Photodynamic therapy of head and neck cancer with different sensitizers, 0000 (29 December 1997); doi: 10.1117/12.297809
Proc. SPIE 3191, Photodynamic therapy of recurrent tumors of oropharyngeal area as an out-patient procedure, 0000 (29 December 1997); doi: 10.1117/12.297810
Proc. SPIE 3191, Influence of drug and light dose in determining PDT efficacy in human pancreatic cancer cells treated with zinc tetrasulfonated phthalocyanines (ZnTSPc), 0000 (29 December 1997); doi: 10.1117/12.297811
Proc. SPIE 3191, Photodynamic therapy of cancer: five-year clinical experience, 0000 (29 December 1997); doi: 10.1117/12.297812
Poster Session
Proc. SPIE 3191, Immunohistochemical observations on tumor suppressor gene p53 status in mouse fibrosarcoma following in-vivo photodynamic therapy: the role of xanthine oxidase activity, 0000 (29 December 1997); doi: 10.1117/12.297813
Proc. SPIE 3191, Detection of numerical chromosomal abnormalities (chr. 1 and 18) before and after photodynamic therapy of human bladder carcinoma cells in vitro, 0000 (29 December 1997); doi: 10.1117/12.297814
Proc. SPIE 3191, Phototoxicity to sulphonamide-derived oral antidiabetics and diuretics: comparative in-vitro and in-vivo investigations, 0000 (29 December 1997); doi: 10.1117/12.297815
Proc. SPIE 3191, In-vitro studies of zinc(II)-phthalocyanine (Zn-PC) for use in photochemotherapy, 0000 (29 December 1997); doi: 10.1117/12.297816
Proc. SPIE 3191, Photo-oxidative stability of various tetra-azaporphyrin derivatives in solution and correlation with semiempirical MO calculations, 0000 (29 December 1997); doi: 10.1117/12.297818
Proc. SPIE 3191, New biotinylated phthalocyanines for the photodynamic therapy of cancer, 0000 (29 December 1997); doi: 10.1117/12.297819
Proc. SPIE 3191, Effect of chlorin e6 and photosensitizer-superoxide dismutase complexes on ion-transporting processes of blood cells, 0000 (29 December 1997); doi: 10.1117/12.297820
Proc. SPIE 3191, Pharmacokinetics evaluation of 132-hydroxy-bacteriopheophorbid-a methyl ester and octa-alpha-butyloxy-zinc phthalocyanine for future application in PDT, 0000 (29 December 1997); doi: 10.1117/12.297821
ALA-PDT
Proc. SPIE 3191, PDT of Barrett's esophagus: kinetics and localization of 5-aminolevulinic acid-induced porphyrin accumulation in the rat esophagus, 0000 (29 December 1997); doi: 10.1117/12.297822
Poster Session
Proc. SPIE 3191, Kinetics of porphyrin partitioning in cells and membranes: investigation of cholesterol effects, 0000 (29 December 1997); doi: 10.1117/12.297823
Proc. SPIE 3191, Porphyrin binding with blood cells, 0000 (29 December 1997); doi: 10.1117/12.297824
Proc. SPIE 3191, Experimental study of simultaneous photodynamic and hyperthermic treatment of Ehrlich ascites carcinoma and A22 hepatoma, 0000 (29 December 1997); doi: 10.1117/12.297825
Proc. SPIE 3191, Avidin-biotin system for targeting delivery of photosensitizers and other cytotoxic agents into malignant tissues, 0000 (29 December 1997); doi: 10.1117/12.297826
Proc. SPIE 3191, Modulation of Photofrin II accumulation in C6 glioma cells by stimulation of beta-adrenergic receptors, 0000 (29 December 1997); doi: 10.1117/12.297827
Basic Studies
Proc. SPIE 3191, Nontumor photodynamic therapy, 0000 (29 December 1997); doi: 10.1117/12.297828
Poster Session
Proc. SPIE 3191, Gd-meso-tetraphenylporphyrins: synthesis, encapsulation into liposomes, and characterization of the resulting preparations, 0000 (29 December 1997); doi: 10.1117/12.297829
Back to Top